Marc Beer sucessfully raised $42 million for Renovia Inc., a company he co-founded with Ramon Iglesias and Yolanda Lorie. Renovia Inc. is based out of Boston and is a company devoted to women’s health, developing a number of different diagnostic and treatment products to treat the common female condition known as pelvic floor disorders. An example of pelvic floor disorders is urinary incontinence, which affects approximately 250 million women around the world. Renovia’s maiden product, Leva successful secured the FDA’s approval in April of this year. Marc Beer raised the $42 million from a group of three healthcare investors, which consists of New York-based Perspective Advisors, Missouri-based Ascension Ventures, and the Longwood Fund. The funds raised by Marc Beer will be earmarked for the development and testing of four more new therapeutic and diagnostic products along with a newer version of Leva. In addition, after the successful completion of a recent $32 million Series B Round, Renovia intends to proceed with the development of several new products to ameliorate pelvic floor disorders and to provide relief for a multitude of women. Renovia’s mission is to provide a means to better diagnose, treat, and improve the lives of the millions of women afflicted with pelvic floor disorders.
Renovia was co-founded by Marc Beer, who is the company’s Chief Executive Officer. Marc Beer has over 25 years of experience in developing and commercializing biotechnology, pharmaceuticals, devices, and diagnostics. In April of the year 2000, Marc Beer founded and became the Chief Executive Officer of ViaCell, a biotech company that specializes in collecting, preserving, and developing umbilical cord blood stem cells, which went public in 2005 due to Marc’s stellar leadership. Prior to founding Viacell, Marc Beer held the position of Vice President of Global Marketing at Genzyme, charged with commercially launching several products that address rare disease populations globally. Before his employment at Genzyme, Marc Beer worked at Abbott Laboratories in sales and marketing roles in the pharmaceutical and diagnostic divisions. Marc Beer also founded Good Start Genetics, Inc. and was the company’s chairman of the board of directors and chairman of the compensation committee. In addition, Marc Beer founded Minerva Neurosciences Inc. and was the company’s chairman of the board, chairman of the compensation committee, and a member of the audit committee. Marc Beer is a graduate of Miami University in Ohio. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing